美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPDR S&P Biotech ETF

151.40

-2.3700-1.54%

盘后：151.13-0.2700-0.18%16:20 EDT

成交量：602.36万

成交额：9.16亿

市值：101.10亿

市盈率：8.30

高：154.12

开：153.43

低：151.10

收：153.77

52周最高：169.89

52周最低：103.43

股本：6,677.50万

流通股本：6,677.50万

量比：0.51

换手率：9.02%

股息：0.54

股息率：0.36%

每股收益(TTM):18.23

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

浙江省：力争到2030年，全省生物医药产业集群营业收入超5000亿元

力争到2030年集群营收超5000亿元浙江全链条支撑生物医药产业发展

前8个月医保统筹基金收入约2.07万亿元

前8个月医保统筹基金收入约2.07万亿元

港股生物医药股开盘下挫，金斯瑞生物跌超15%

生物医药板块大幅回调恒生生物科技指数跌3.15%

医疗保健行业综述：市场观察

医疗保健行业综述：市场观察

医疗健康行业综述：市场观察

小摩：不太担心利率上升影响中国医疗健康行业继续看好生物科技及CXO

特朗普：感谢凯斯勒推动老年医疗创新

特朗普社媒动态

生物医药板块走高恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%

生物医药板块局部活跃金斯瑞生物科技（01548）涨4.67%、百济神州（06160）涨2.92%

特朗普：我们上任后发现，在狡诈的乔·拜登以及民主党执政时期，有近百万户通过奥巴马医改购买医疗保险的家庭被严重多收费用，

National Healthcare Properties宣布2026年第四季度普通股股息

医疗健康板块综述：市场动态

医疗保健行业综述：市场观察

医疗保健板块综述：市场观察

医疗健康板块综述：市场观察

实时行情-TD Cowen表示，人工智能有望为医院带来利润提升

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/XBI/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":151.4,"timestamp":1791835200000,"preClose":153.77,"halted":0,"volume":6023619,"hourTrading":{"tag":"盘后","latestPrice":151.13,"preClose":151.4,"latestTime":"16:20 EDT","volume":3415,"amount":516446.01050000003,"timestamp":1791836430066,"change":-0.27,"changeRate":-0.001783,"amplitude":0.002567},"delay":0,"changeRate":-0.015412629251479511,"floatShares":66775000,"shares":66775000,"eps":18.23,"marketStatus":"盘后交易","change":-2.37,"latestTime":"10-12 16:21:10 EDT","open":153.43,"high":154.12,"low":151.1,"amount":916082217.6723001,"amplitude":0.01964,"askPrice":151.69,"askSize":200,"bidPrice":151.13,"bidSize":200,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":153.77,"sharesOutstanding":63325000,"nav":153.722719,"aum":10430086474.925,"dividendRate":0.003555,"bidAskSpread":0.000294,"preHourTrading":{"tag":"盘前","latestPrice":153.9,"preClose":153.77,"latestTime":"09:26 EDT","volume":6687,"amount":1030664.76894,"timestamp":1791811594916,"change":0.13,"changeRate":0.000845,"amplitude":0.00676},"postHourTrading":{"tag":"盘后","latestPrice":151.13,"preClose":151.4,"latestTime":"16:20 EDT","volume":3415,"amount":516446.01050000003,"timestamp":1791836430066,"change":-0.27,"changeRate":-0.001783,"amplitude":0.002567},"volumeRatio":0.512116,"impliedVol":0.3251,"impliedVolPercentile":0.6813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66775000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.512116,"shares":66775000,"dividePrice":0.5382,"high":154.12,"amplitude":0.01964,"preClose":153.77,"low":151.1,"week52Low":103.43,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":151.4,"eps":18.23,"divideRate":0.003555,"volume":6023619,"delay":0,"ttmEps":18.23,"open":153.43,"prevYearClose":121.93,"prevWeekClose":153.77,"prevMonthClose":157.68,"prevQuarterClose":157.68,"fiveDayClose":156.19,"twentyDayClose":157.6,"sixtyDayClose":154.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673764067","title":"浙江省：力争到2030年，全省生物医药产业集群营业收入超5000亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673764067","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673764067?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 12:16","pubTimestamp":1791346571,"startTime":"0","endTime":"0","summary":"金吾财讯 | 浙江省政府办公厅日前印发《关于促进生物医药产业高质量发展的指导意见》，明确提出，力争到2030年，全省规模以上生物医药企业研发费用占营业收入比重的7%左右，在关键共性技术、前沿引领领域实现重要突破，生物医药产业集群营业收入超5000亿元。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MTA4MTkwNzU5Nzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MTA4MTkwNzU5Nzkx.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993212","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","161726","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673620090","title":"力争到2030年集群营收超5000亿元 浙江全链条支撑生物医药产业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2673620090","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673620090?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 11:30","pubTimestamp":1791343810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4581","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673906252","title":"前8个月医保统筹基金收入约2.07万亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673906252","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673906252?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 10:30","pubTimestamp":1791340225,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据新华社报道，国家医保局日前发布数据，2026年1月至8月，我国基本医疗保险（含生育保险）统筹基金总收入20727.72亿元，基本医疗保险（含生育保险）统筹基金总支出15504.14亿元，医保基金整体运行平稳。数据显示，在基本医疗保险（含生育保险）统筹基金收入方面，职工基本医疗保险（含生育保险）统筹基金收入12813.17亿元，城乡居民基本医疗保险统筹基金收入7914.55亿元。2026年前8个月，职工基本医疗保险（含生育保险）统筹基金支出8893.49亿元，其中生育保险基金待遇支出889.29亿元；城乡居民基本医疗保险统筹基金支出6610.65亿元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993194","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XBI","BK4581","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062881","title":"前8个月医保统筹基金收入约2.07万亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062881","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062881?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 10:21","pubTimestamp":1791339690,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673626064","title":"港股生物医药股开盘下挫，金斯瑞生物跌超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673626064","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673626064?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 09:42","pubTimestamp":1791337320,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端10月7日消息，港股生物医药股开盘下挫，金斯瑞生物跌超15%，再鼎医药跌超7%，泰格医药、君实生物跌超6%，荣昌生物、诺诚健华跌超4%。渤海证券指出，近期AI制药催化密集，行业焦点逐步从模型能力转向湿实验验证效率等方面，建议关注AI制药相关基因合成、蛋白表达、试剂耗材、动物模型及临床试验等细分赛道的投资机遇。同时，2026年ESMO年会即将召开，优异临床数据有望读出，带来板块密集催化，建议关注创新药、CXO及生命科学上游产业链等的投资机遇。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-10-07/doc-iniukhki8273392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","VXUS","BK4588","BK4585","BK4581","161726","XBI","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673064659","title":"生物医药板块大幅回调 恒生生物科技指数跌3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673064659","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673064659?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 09:35","pubTimestamp":1791336927,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块大幅回调，截至发稿，恒生生物科技指数跌3.15%，恒生医疗保健指数跌2.73%，万得港股中国创新药指数跌2.39%。个股方面，金斯瑞生物科技（01548）跌14.81%，再鼎医药（09688）跌4.47%，药明合联（02268）跌3.68%，药明生物（02269）跌2.50%，百济神州（06160）跌1.18%，诺诚健华（09969）跌1.43%，康诺亚-B（02162）跌1.32%，康方生物（09926）跌1.45%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993174","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","09926","LU0456827905.SGD","LU0348784397.USD","IE00B0JY6N72.USD","LU3063872942.SGD","BK1521","LU0228659784.USD","LU0572944931.SGD","LU0561508036.HKD","01548","LU0320764243.SGD","XBI","LU2488822045.USD","LU0348766576.USD","LU0828237510.HKD","BK1574","LU0856984785.SGD","02269","LU0211977185.USD","KURE","LU0320764599.SGD","LU0417516738.SGD","SG9999002562.SGD","BK1141","09688","LU0244354667.USD","02162","BK1161","399441","161726","BK4588","LU0052750758.USD","LU1720050803.USD","LU0456846285.SGD","LU0588546209.SGD","09969","SG9999002463.SGD","IE00B543WZ88.USD","06160","LU1880383366.USD","LU1794554557.SGD","LU1242518931.SGD","LU0359202008.SGD","SG9999014674.SGD","LU1242518857.USD","02268","LU0348825331.USD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118919341","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1118919341","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118919341?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 04:54","pubTimestamp":1791320069,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察。“赛诺菲现在可以着手将其300亿至400亿欧元的资产负债表能力投入到业务拓展中，”分析师称。分析师称，Berenberg接下来关注的下一个更新数据是frexalimab治疗多发性硬化症的后期试验，以及brivekimig治疗皮肤疾病化脓性汗腺炎的中期试验，均预计于2027年下半年公布。赛诺菲股价上涨1%。泰国医疗保健公司的盈利不太可能因近期部分地区洪水而受到大幅拖累，马来亚银行的Nontapat Sahakitpinyo在一份报告中表示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","BK4585","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160573907","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1160573907","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160573907?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 00:26","pubTimestamp":1791304017,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察汇总。赛诺菲股价上涨1%。该美国投行表示，此前市场对盐野义制药可能寻求何种并购存在一些担忧。1749 ET - 杰富瑞认为，CSL与Alentis Therapeutics达成联合开发和推广一种罕见肾脏及肝脏疾病疗法的协议，体现了CSL当前的研发理念。该疗法名为lixudebart，正在一项2期试验中用于评估治疗ANCA相关性血管炎和快速进展性肾小球肾炎患者的效果。杰富瑞估计，该疾病在美国的年均可及市场总额为9亿至16亿美元，并补充称这一评估较为保守。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197928159","title":"医疗健康行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1197928159","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197928159?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 16:25","pubTimestamp":1791275116,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场观察。“赛诺菲现在可以着手将300亿至400亿欧元的资产负债表能力用于业务拓展，”分析师称。由于赛诺菲与再生元将联合开发的候选药物尚处早期阶段，这家法国药企近期可期的关键研究结果有限，Berenberg指出。赛诺菲股价上涨1%。泰国医疗健康公司的盈利不太可能受到近期部分地区洪灾的严重拖累，马来亚银行的Nontapat Sahakitpinyo在一份报告中表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673035134","title":"小摩：不太担心利率上升影响中国医疗健康行业 继续看好生物科技及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035134","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673035134?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 11:32","pubTimestamp":1791257520,"startTime":"0","endTime":"0","summary":"另外，该行预期本轮加息周期将于12月再加息一次后结束，而非延续至明年的长期紧缩，因此对利率上升影响中国医疗健康估值并不太担心，并继续看好生物科技及CXO子板块。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","KURE","06990","LU1974910355.USD","LABU","XLBI","CXO","IEIH","XBI","159760","EQRR","IE0034235295.USD","JPO","LU1670627923.USD","XLV","IBBJ","MEDX","VHT","IXG","GDOC","FNCL","03696","LNGR","159837","TRUF","LU0708995153.HKD","KBWB","02269","IYF","TFNS","VFH","JPMO","LU2168564065.EUR","UYG","XLF","01548","PEX","SYNB","LU0345769631.USD","02359","LU0345769128.USD","FTXO","IE00BKDWB100.SGD","HBImain","IYG","LU0976567544.SGD","LU0572944931.SGD","WX","IXJ","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109627217","title":"特朗普：感谢凯斯勒推动老年医疗创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1109627217","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109627217?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 11:04","pubTimestamp":1791255864,"startTime":"0","endTime":"0","summary":"美国总统唐纳德·特朗普10月6日在社交媒体X上发文，感谢并赞扬其老龄化医疗保健顾问霍华德·凯斯勒为65岁及以上美国老年人所做的工作。特朗普在帖文中称凯斯勒是“非常成功的创业者和创新者”，曾帮助转型金融服务业，如今将“同样的远见、精力和经验”带入医疗保健领域。特朗普强调“Our Seniors built this Country. They deserve the BEST Healthcare in the World, and we are going to make sure they get it.”（我们的老年人建设了这个国家。）他最后对凯斯勒说：“Keep up the great work!”","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGCV","HBMD","BK4211","HEAL","BK4585","XBI","BK4550","LNGR","BK4581","NOBL","IXJ","DTEC","LABU","BK4588","XLV","VHT","THMZ","GINN","TCAF","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673033818","title":"生物医药板块走高 恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673033818","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673033818?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 10:01","pubTimestamp":1791252073,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走高，恒生生物科技指数涨2.32%，恒生医疗保健指数涨2.19%，万得中国创新药指数涨2.15%。个股方面，再鼎医药涨6.97%，金斯瑞生物科技涨5.30%，君实生物涨3.07%，药明生物涨3.07%，康方生物涨2.92%，康诺亚-B涨2.33%，泰格医药涨1.90%，诺诚健华涨1.87%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993104","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU1720050803.USD","LU0708995153.HKD","IE00B543WZ88.USD","XBI","BK1574","09926","LU0359202008.SGD","SG9999002463.SGD","09688","01877","LU0052750758.USD","LU2039709279.SGD","BK1141","BK1515","399441","LU0348735423.USD","LU0516422952.EUR","02162","LU0456827905.SGD","LU1880383366.USD","LU2778985437.USD","LU0327786744.USD","BK4581","LU0140636845.USD","LU0708995583.HKD","IE00BPRC5H50.USD","LU1794554557.SGD","LU0417516902.SGD","09969","HK0000320223.HKD","LU0181495838.USD","LU0039217434.USD","SG9999002562.SGD","LU0320764599.SGD","02269","03347","LU0051755006.USD","LU0128522744.USD","LU0634319403.HKD","LU0561508036.HKD","LU0307460666.USD","LU0348784397.USD","01548","LU2488822045.USD","LU0516423174.USD","161726","KURE","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673770524","title":"生物医药板块局部活跃 金斯瑞生物科技（01548）涨4.67%、百济神州（06160）涨2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673770524","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673770524?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 14:10","pubTimestamp":1791180649,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块局部表现活跃，截至发稿，金斯瑞生物科技 涨4.67%，百济神州涨2.92%，药明生物涨1.65%，药明康德涨1.14%。消息面上，山西证券表示，AI模型公司以及众多MNC对AI高度重视已充分说明AI制药是未来AI应用的重要方向之一。短期看，通过AI模型设计的大量药物分子有望转化成上游服务企业的新增订单；中长期看，AI制药未来有望大幅提高药物研发效率和研发质量。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874905.USD","161726","LU0516422440.USD","LU0516422366.SGD","LU2125910500.SGD","IE00B0JY6N72.USD","LU0417516902.SGD","ONC","LU1242518857.USD","BK4585","06160","LU0348767384.USD","LU2476274720.SGD","XBI","LU0051755006.USD","LU0540923850.HKD","BK4581","LU0039217434.USD","LU2045819591.USD","01548","LU0828237510.HKD","LU2778985437.USD","LU0708995583.HKD","688235","HK0000306701.USD","LU0320764599.SGD","LU0572944931.SGD","LU0634319403.HKD","BK1610","LU0327786744.USD","399441","02269","HK0000306685.HKD","LU0128526141.USD","LU0320764243.SGD","LU0456827905.SGD","LU0561508036.HKD","LU2039709279.SGD","LU0211977185.USD","LU0181495838.USD","KURE","LU1770034418.SGD","02359","LU0228659784.USD","LU0307460666.USD","BK4526","LU0819121731.USD","LU0348766576.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672795899","title":"特朗普： 我们上任后发现，在狡诈的乔·拜登以及民主党执政时期，有近百万户通过奥巴马医改购买医疗保险的家庭被严重多收费用，","url":"https://stock-news.laohu8.com/highlight/detail?id=2672795899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672795899?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 09:28","pubTimestamp":1790904509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XBI","XLV","BK4588","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141343649","title":"National Healthcare Properties宣布2026年第四季度普通股股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1141343649","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141343649?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 04:31","pubTimestamp":1790886665,"startTime":"0","endTime":"0","summary":"National Healthcare Properties, Inc.今日宣布，其董事会已批准派发每股普通股0.075美元的季度股息。该股息将以现金形式于2026年10月16日支付给截至2026年10月12日营业结束时登记在册的股东。National Healthcare Properties, Inc.是一家自我管理的房地产投资信托基金，专注于收购、持有并投资多元化的医疗保健房地产组合，重点是为美国不断增长的老年人口提供养老住房。最后，公司无义务更新或修订任何前瞻性声明，也无义务更新实际结果可能与任何前瞻性声明中预测结果存在差异的原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","REET","SRU.SI","BK4585","JJJ.SI","BK4581","NHP","XBI","SRT.SI","CFA.SI","BK4588","CLR.SI","XLV","GLS.SI","BK4225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113616442","title":"医疗健康板块综述：市场动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1113616442","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113616442?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 00:28","pubTimestamp":1790872108,"startTime":"0","endTime":"0","summary":"市场动态最新汇总，聚焦医疗健康板块。赛诺菲股价上涨0.6%。Imricor Medical Systems自9月初进入ASX 300指数以来股价已下跌逾20%，Morgans的看多分析师认为，这为投资者创造了绝佳的买入机会。Imricor周三收于1.585澳元，此前8月曾触及2.07澳元的高点。Morgans认为，季节性疲软和利率上升可能是导致股价下跌的原因。近期消息面偏向积极。Morgans对Imricor给予投机性买入评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XLV","BK4581","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129884397","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1129884397","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129884397?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 16:24","pubTimestamp":1790843092,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察。分析师补充称，赛诺菲还需采取其他关键举措来填补该联盟重磅药物Dupixent专利在2031至2032年间到期后留下的销售缺口，包括潜在收购以及达成和解以推迟仿制版本的上市。赛诺菲股价上涨0.6%。阿斯利康正在一项晚期临床试验中测试其Datroway抗体药物偶联物与其PD-L1药物Imfinzi联合用于肺癌治疗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XBI","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167055452","title":"医疗保健板块综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1167055452","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167055452?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 04:55","pubTimestamp":1790801739,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察汇编。阿斯利康正在一项晚期临床试验中测试其Datroway抗体药物偶联物与其PD-L1药物Imfinzi联合用于肺癌治疗。该警告信提醒其美国工厂存在监管机构所称的严重违规行为。Fresenius Kabi回应称未发现患者安全方面的问题。股价上涨1.4%至184.25澳元。IHH表示，在涉及第一三共及前Fortis发起人的纠纷中，其不受财务索赔约束。股价上涨0.1%至7.88林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","LABU","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182869669","title":"医疗健康板块综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1182869669","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182869669?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 00:24","pubTimestamp":1790785451,"startTime":"0","endTime":"0","summary":"阿斯利康正在一项晚期临床试验中测试其Datroway抗体药物偶联物与其PD-L1药物Imfinzi联合用于肺癌治疗。Fresenius Kabi回应称，未发现任何患者安全问题。2211 ET - 花旗分析师Megat Fais在一份报告中表示，IHH Healthcare近期的股价疲软很可能是一个增强的买入机会，与Fortis相关的诉讼担忧预计对运营影响有限。IHH表示，其不受涉及第一三共及前Fortis发起人的纠纷中的财务索赔约束。股价上涨0.1%至7.88林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","BK4581","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207596","title":"实时行情-TD Cowen表示，人工智能有望为医院带来利润提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207596","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207596?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 21:18","pubTimestamp":1790774327,"startTime":"0","endTime":"0","summary":"TD Cowen表示，计费和收款是短期内最明显的机遇。TD Cowen表示，拥有强大数据和集中化运营的大型医疗系统有望率先受益。TD Cowen警告称，保险公司和政府项目最终可能会通过降低支付率来应对医院的成本节约，因此尽早采用该技术至关重要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4S45M15F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211327993.USD","IHF","LU0211328371.USD","IE00B775SV38.USD","LU0882574055.USD","LU0648000940.SGD","LU1267930490.SGD","LU0868494617.USD","LU1084165304.USD","SG9999014013.SGD","BK4504","LABU","LU0187121727.USD","LU0130102774.USD","SG9999014005.SGD","LU0708994859.HKD","BK4585","LU1201861249.SGD","UHS","LU0203345920.USD","THC","LU0128525929.USD","XBI","IE00B3S45H60.SGD","XLV","BK4185","LU1267930573.SGD","LU0310800379.SGD","LU0114720955.EUR","HCA","SG9999014039.USD","LU1489326972.SGD","LU1201861165.SGD","BK4581","LU0980610538.SGD","LU0648001328.SGD","LU1150488135.SGD","LU1150488218.USD","LU0963586101.USD","LU0310799852.SGD","LU1261432733.SGD","LU2324357040.USD","LU0068578508.USD","SG9999014021.USD","LU0433182093.SGD","LU0130103400.USD","LU0203347892.USD","LU0029864427.USD","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}